Health
Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer
A joint research group consisting of Saitama Medical University and Meiji Holdings Co., Ltd. today announced results from a study demonstrating that people living with non-small cell lung cancer (NSCLC) who consumed yogurt containing an exopolysaccharide produced by Lactobacillus delbrueckii subsp. bulgaricus OLL1073R–1 (R–1 EPS) developed and owned by Meiji, in parallel with treatment using immune checkpoint inhibitors1 (ICIs), showed tendency toward higher objective response rates2 (ORR) and d
About this update from Meiji Holdings Co., Ltd.
[{"type":"text","content":"— Findings Show Higher Levels of Th7R Immune Cells in the Blood, Suggesting Higher Response to Immunotherapy Due to R-1 EPS, a Metabolite Produced by Lactobacillus Bulgaricus OLL1073R–1 —","length":192,"tagName":"p","attribs":{}},{"type":"text","content":"— Results Presented at American Association for Cancer Research (AACR) Annual Meeting 2026 — ","length":92,"tagName":"p","attribs":{}},{"type":"text","content":"TOKYO, April 17, 2026 /PRNewswire/ -- A joint research group consisting of Saitama Medical University and Meiji Holdings Co., Ltd. today announced results from a study demonstrating that people living with non-small cell lung cancer (NSCLC) who consumed yogurt containing an exopolysaccharide produced by Lactobacillus delbrueckii subsp. bulgaricus OLL1073R–1 (R–1 EPS) developed and owned by Meiji, in parallel with treatment using immune checkpoint inhibitors1 (ICIs), showed tendency toward higher objective response rates2 (ORR) and disease control rates2 (DCR) to the therapy. In addition, the researchers found that levels of Th7R immune cells—considered to be a key factor correlated with the efficacy of immunotherapy—were maintained at higher levels in the blood of the patients who participated in the study. These findings were presented at the American Association for Cancer Research (AACR) Annual Meeting 2026 held in San Diego, California.","length":999,"tagName":"p"},{"type":"image","alt":"An electron micrograph of R-1 EPS, an exo-polysaccharide produced by Meiji’s proprietary strain of lactic acid bacteria.","displaySize":"","headline":null,"caption":"An electron micrograph of R-1 EPS, an exo-polysaccharide produced by Meiji’s proprietary strain of lactic acid bacteria.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":287,"url":"https://media.zenfs.com/en/prnewswire.com/f56b8b73cf367265504ecfab8d40aa8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nAyIKc9Vv5duPNEnOmdoMw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUwNg--/https://media.zenfs.com/en/prnewswire.com/f56b8b73cf367265504ecfab8d40aa8f","width":400,"height":287}},"href":"https://mma.prnewswire.com/media/2959451/Meiji_Electron_Micrograph_R_1_EPS.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"NSCLC is the most common type of lung cancer, making ...